Peyer James's Form 4 filing
Faeth Therapeutics, Inc. (FTH) · filed Jan 21, 2022
- Accession no.
- 0001567619-22-001464
- Filed
- Jan 21, 2022
- Trade date
- Jan 19-20, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $154.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Peyer JamesCIK 0001843594 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2022 | Common Stock | PPurchaseAcquired | +10,244 | $4.97 | +$50,912.68 | 4,995,876 | Indirect | Duplicate filing |
| Jan 20, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $5.17 | +$103,400 | 5,015,876 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.